The association between diverse serum folate with MAFLD and liver fibrosis based on NHANES 2017–2020

The association between diverse serum folate with MAFLD and liver fibrosis based on NHANES 2017–2020

BackgroundMetabolically Associated Fatty Liver Disease (MAFLD) marks a progression from the previous paradigm of Non-Alcoholic Fatty Liver Disease (NAFLD), presenting a redefined diagnostic framework that accentuates metabolic factors while recognizing non-alcoholic contributors. In our investigatio...

Full description

Bibliographic Details
Main Authors:	Jiacheng Cai, Dahua Chen, Wenjing Luo, Feng Xu, Xiaofeng Feng, Liangshun Zhang, Huiwei Liu, Jianwei Shen, Hua Ye
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-03-01
Series:	Frontiers in Nutrition
Subjects:	NHANES MAFLD liver fibrosis total folate 5-MTHF
Online Access:	https://www.frontiersin.org/articles/10.3389/fnut.2024.1366843/full

Similar Items

NAFLD or MAFLD: Which Has Closer Association With All-Cause and Cause-Specific Mortality?—Results From NHANES III
by: Qi Huang, et al.
Published: (2021-07-01)

Variations in folate prescriptions for patients with the MTHFR genetic polymorphisms: A case series study
by: Carolyn Jane Ledowsky, et al.
Published: (2023-06-01)

Dietary Quality and Relationships with Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) among United States Adults, Results from NHANES 2017–2018
by: Ting Tian, et al.
Published: (2022-10-01)

Periconceptional Folate Supplementation in Women after Bariatric Surgery—A Narrative Review
by: An-Katrien Vynckier, et al.
Published: (2021-05-01)

Association between daidzein intake and metabolic associated fatty liver disease: A cross-sectional study from NHANES 2017–2018
by: Zheng Yang, et al.
Published: (2023-02-01)

Negative associations between folate and bacterial vaginosis in the NHANES 2001 to 2004
by: Ting-Ting Cui, et al.
Published: (2023-07-01)

Pathogenetic substantiation of personified correction of folate cycle disorders using a complex with metapholine for the congenital malformations prevention
by: І. В. Руденко, et al.
Published: (2020-05-01)

Performance of noninvasive seromarkers in predicting liver fibrosis among MAFLD patients with or without viral hepatitis
by: Chung‐Feng Huang, et al.
Published: (2024-04-01)

Association between blood heavy metal exposure levels and risk of metabolic dysfunction associated fatty liver disease in adults: 2015–2020 NHANES large cross-sectional study
by: Song Tang, et al.
Published: (2024-02-01)

Serum high-sensitive C-reactive protein is a simple indicator for all-cause among individuals with MAFLD
by: Jiaofeng Huang, et al.
Published: (2022-10-01)

Potential screening indicators for early diagnosis of NAFLD/MAFLD and liver fibrosis: Triglyceride glucose index–related parameters
by: Yan Xue, et al.
Published: (2022-09-01)

Analysis of the mediating role of BMI in associations of different folate forms with hepatic steatosis and liver fibrosis in adolescents in the USA: results from the NHANES 2017-2018
by: Jingli Wen, et al.
Published: (2023-12-01)

Lead exposure was associated with liver fibrosis in subjects without known chronic liver disease: An analysis of NHANES 2017–2020
by: Zhiqiang Zhang, et al.
Published: (2022-10-01)

Lead exposure as a causative factor for metabolic associated fatty liver disease (MAFLD) and a lead exposure related nomogram for MAFLD prevalence
by: Chenyu Yang, et al.
Published: (2022-10-01)

MAFLD: How is it different from NAFLD?
by: Cameron Gofton, et al.
Published: (2023-02-01)

Effect of MAFLD on albuminuria and the interaction between MAFLD and diabetes on albuminuria
by: Yufang Liu, et al.
Published: (2024-02-01)

Higher serum chromium level may be associated with the presentation of depression in patients with metabolic dysfunction-associated fatty liver disease: evidence from NHANES survey
by: Xiuhua Li, et al.
Published: (2024-03-01)

Serum Micro-RNA-122 Level as a Simple Noninvasive Marker of MAFLD Severity
by: Hegazy MA, et al.
Published: (2021-05-01)

Study on inflammation and fibrogenesis in MAFLD from 2000 to 2022: a bibliometric analysis
by: Kuanhong Luo, et al.
Published: (2023-08-01)

The associations of dietary folate and serum folate with lipid profiles: findings from the national health and nutrition examination survey 2011–2016
by: Yunfu Feng, et al.
Published: (2023-03-01)

Folic Acid, Folinic Acid, 5 Methyl TetraHydroFolate Supplementation for Mutations That Affect Epigenesis through the Folate and One-Carbon Cycles
by: Yves Menezo, et al.
Published: (2022-01-01)

Red blood cell folate and benign prostatic hyperplasia: results from the NHANES 2001-2008
by: TingTing Chen, et al.
Published: (2024-12-01)

Probiotic consumption and hepatic steatosis: results from the NHANES 2011–2016 and Mendelian randomization study
by: Yancheng Song, et al.
Published: (2024-04-01)

Association of serum folate with prevalence of non-alcoholic fatty liver disease among adults (NHANES 2011–2018)
by: Baodong Yao, et al.
Published: (2023-04-01)

Impaired Function of Solute Carrier Family 19 Leads to Low Folate Levels and Lipid Droplet Accumulation in Hepatocytes
by: Ainara Cano, et al.
Published: (2023-01-01)

Hyperhomocysteinemia in hypofertile male patients can be alleviated by supplementation with 5MTHF associated with one carbon cycle support
by: Arthur Clement, et al.
Published: (2023-08-01)

Association of multiple serum minerals and vitamins with metabolic dysfunction-associated fatty liver disease in US adults: National Health and Nutrition Examination Survey 2017–2018
by: Peisen Guo, et al.
Published: (2024-03-01)

Identifying advanced MAFLD in a cohort of T2DM and clinical features
by: Ana Maria Sanchez-Bao, et al.
Published: (2023-02-01)

Circadian Misalignment Rather Than Sleep Duration is Associated with MAFLD: A Population-Based Propensity Score-Matched Study
by: Weng Z, et al.
Published: (2021-01-01)

Editorial: Community series - liver fibrosis and MAFLD: from molecular aspects to novel pharmacological strategies, volume II
by: Ana Sandoval-Rodriguez, et al.
Published: (2024-02-01)

Metabolic Syndrome Severity Predicts Mortality in Nonalcoholic Fatty Liver Disease
by: Mohamed I. Elsaid, et al.
Published: (2022-01-01)

Molecular Advances in MAFLD—A Link between Sphingolipids and Extracellular Matrix in Development and Progression to Fibrosis
by: Adrian Kołakowski, et al.
Published: (2022-09-01)

Risk of the Development of Fibrosis in Metabolic Dysfunction-Associated Fatty Liver Disease in Patients with Rheumatoid Arthritis
by: Murat Aydın, et al.
Published: (2023-11-01)

Liver fibrosis and MAFLD: the exploration of multi-drug combination therapy strategies
by: Qingfu Dong, et al.
Published: (2023-04-01)

Reduced Kidney Function Is Associated with Increasing Red Blood Cell Folate Concentration and Changes in Folate Form Distributions (NHANES 2011–2018)
by: Arick Wang, et al.
Published: (2022-03-01)

From NAFLD to MAFLD: Definition, Pathophysiological Basis and Cardiovascular Implications
by: Andrea Boccatonda, et al.
Published: (2023-03-01)

Cardiovascular and renal burdens among patients with MAFLD and NAFLD in China
by: Yuying Wang, et al.
Published: (2022-09-01)

Non-Linear Association between Folate/Vitamin B12 Status and Cognitive Function in Older Adults
by: Zhe Ding, et al.
Published: (2022-06-01)

Curcumin and Biochemical Parameters in Metabolic-Associated Fatty Liver Disease (MAFLD)—A Review
by: Gracjan Różański, et al.
Published: (2021-07-01)

Dietary creatine and cancer risk in the U.S. population: NHANES 2017–2020
by: Sergej M. Ostojic, et al.
Published: (2023-09-01)